Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment

Cell Cycle

Volumn 12, Issue 2, 2013, Pages 322-331

  Tian, Chen ^c   Zheng, Guoguang ^a   Cao, Zhipan ^a   Li, Qiao ^a   Ju, Zhenyu ^b   Wang, Jinhong ^a   Yuan, Weiping ^a   Cheng, Tao ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Hematopoietic stem cells; Hes1; Leukemia

Indexed keywords

MESSENGER RNA; PROTEIN P21; STEM CELL FACTOR; TRANSCRIPTION FACTOR HES 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMOGENESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84873619091     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23160     Document Type: Article

References (37)

1. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 2001; 938:83-95; PMID:11458529; http://dx.doi.org/10.1111/j.1749- 6632.2001.tb03577.x.
2. Christopherson KW 2nd, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305:1000-3; PMID:15310902; http://dx.doi.org/10.1126/science.1097071.
3. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841-6; PMID:14574413; http://dx.doi.org/10.1038/nature02040.
4. Iscove NN, Nawa K. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Curr Biol 1997; 7:805-8; PMID:9368765; http://dx.doi.org/10.1016/S0960-9822(06)00341-1.
5. Rujkijyanont P, Beyene J, Wei K, Khan F, Dror Y. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome. Br J Haematol 2007; 137:537-44; PMID:17539775; http://dx.doi.org/10.1111/j.1365-2141.2007.06608.x.
6. Chatterjee S, Dutta RK, Basak P, Das P, Das M, Pereira JA, et al. Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia: an animal model to study the possible disease pathology. Stem Cells Int 2010; 2010:932354; PMID:21048856; http://dx.doi.org/10.4061/2010/ 932354.
7. Notta F, Mullighan CG, Wang JC, Poeppl A, Doulatov S, Phillips LA, et al. Evolution of human BCRABL1 lymphoblastic leukaemia-initiating cells. Nature 2011; 469:362-7; PMID:21248843; http://dx.doi.org/10.1038/nature09733.
8. Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004; 23:7256-66; PMID:15378085; http://dx.doi.org/10.1038/sj.onc.1207945.
9. Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008; 322:1861-5; PMID:19095944; http://dx.doi.org/10.1126/science.1164390.
10. Hu X, Shen H, Tian C, Yu H, Zheng G, XuFeng R, et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model. Blood 2009; 114:3783-92; PMID:19652197; http://dx.doi.org/10.1182/blood-2009-06- 227843.
11. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551-5; PMID:7954821; http://dx.doi.org/10.1016/0092-8674(94)90540-1.
12. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149- 63; PMID:7758941; http://dx.doi.org/10.1101/ gad.9.10.1149.
13. Boyer MJ, Cheng T. The CDK inhibitors: potential targets for therapeutic stem cell manipulations? Gene Ther 2008; 15:117-25; PMID:17989702; http://dx.doi.org/10.1038/sj.gt.3303064.
14. Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, et al. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 2011; 9:247- 61; PMID:21885020; http://dx.doi.org/10.1016/j.stem.2011.07.003.
15. Li J. Quiescence regulators for hematopoietic stem cell. Exp Hematol 2011; 39:511-20; PMID:21288477; http://dx.doi.org/10.1016/j.exphem.2011.01.008.
16. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804- 8; PMID:10710306; http://dx.doi.org/10.1126/science.287.5459.1804.
17. Yu H, Yuan Y, Shen H, Cheng T. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 2006; 107:1200-6; PMID:16234365; http://dx.doi.org/10.1182/blood-2005-02-0685.
18. Cheng T, Shen H, Rodrigues N, Stier S, Scadden DT. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood 2001; 98:3643- 9; PMID:11739168; http://dx.doi.org/10.1182/blood.V98.13.3643.
19. Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095-100; PMID:18719287; http://dx.doi.org/10.1126/science.1155998.
20. Tomita K, Hattori M, Nakamura E, Nakanishi S, Minato N, Kageyama R. The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev 1999; 13:1203-10; PMID:10323870; http://dx.doi.org/10.1101/gad.13.9.1203.
21. Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L, et al. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells 2006; 24:876-88; PMID:16513761; http://dx.doi.org/10.1634/stemcells.2005-0598.
22. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481:457-62; PMID:22281595; http://dx.doi.org/10.1038/nature10783.
23. Nie Y, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 2008; 205:777-83; PMID:18378795; http://dx.doi.org/10.1084/jem.20072513.
24. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006; 25:977-88; PMID:17174120; http://dx.doi.org/10.1016/j.immuni.2006.10.016.
25. Kipreos ET, Pagano M. The F-box protein family. Genome Biol 2000; 1:S3002; PMID:11178263; http://dx.doi.org/10.1186/gb-2000-1-5-reviews3002.
26. Barbash O, Diehl JA. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough. Cell Cycle 2008; 7:2983-6; PMID:18818515; http://dx.doi.org/10.4161/ cc.7.19.6775.
27. Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307-13; PMID:18948752; http://dx.doi.org/10.4161/cc.7.21.6931.
28. Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, et al. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev 2008; 22:986- 91; PMID:18367647; http://dx.doi.org/10.1101/gad.1621808.
29. Stier S, Cheng T, Forkert R, Lutz C, Dombkowski DM, Zhang JL, et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 2003; 102:1260-6; PMID:12702511; http://dx.doi.org/10.1182/ blood-2002-10-3053.
30. Davis RL, Turner DL. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001; 20:8342-57; PMID:11840327; http://dx.doi.org/10.1038/sj.onc.1205094.
31. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature 1995; 377:355-8; PMID:7566092; http://dx.doi.org/10.1038/377355a0.
32. Jarriault S, Le Bail O, Hirsinger E, Pourquié O, Logeat F, Strong CF, et al. Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 1998; 18:7423-31; PMID:9819428.
33. Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, et al. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 2010; 115:2872-81; PMID:19861684; http://dx.doi.org/10.1182/blood-2009-05-222836.
34. Kaneta M, Osawa M, Sudo K, Nakauchi H, Farr AG, Takahama Y. A role for pref-1 and HES-1 in thymocyte development. J Immunol 2000; 164:256-64; PMID:10605019.
35. Kageyama R, Ohtsuka T, Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007; 134:1243- 51; PMID:17329370; http://dx.doi.org/10.1242/dev.000786.
36. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, et al. Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435:959- 63; PMID:15959515; http://dx.doi.org/10.1038/nature03659.
37. Zanotti S, Smerdel-Ramoya A, Canalis E. HES1 (hairy and enhancer of split 1) is a determinant of bone mass. J Biol Chem 2011; 286:2648-57; PMID:21084301; http://dx.doi.org/10.1074/jbc.M110.183038.